Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
British Journal of Clinical Pharmacology
|
August 29, 2022
An allopurinol adherence tool using plasma oxypurinol concentrations
Natalia Smith-Diaz, Sophie L Stocker, Lisa K Stamp, et al.
British Journal of Clinical Pharmacology
|
March 6, 2014
Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran
Paul K L Chin, David M Patterson, Mei Zhang, et al.
British Journal of Clinical Pharmacology
|
March 14, 2018
'Massive' metformin overdose
Angela L Chiew, Daniel F B Wright, Nicola M Dobos, et al.
Clinical and Translational Science
|
August 25, 2019
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration
Lisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Therapeutic Drug Monitoring
|
November 18, 2016
Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool
Shamin M Saffian, Stephen B Duffull, Rebecca L Roberts, et al.
British Journal of Clinical Pharmacology
|
January 18, 2018
The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool
Daniel F B Wright, Nicola Dalbeth, Amanda J Phipps-Green, et al.
Nephrology (Carlton, Vic.)
|
April 16, 2024
The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout
Luke C Wilson, Jacob Ward, Daniel F B Wright, et al.
ACR Open Rheumatology
|
April 9, 2024
Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study
Toni J F Michael, Daniel F B Wright, Jian S Chan, et al.
European Journal of Clinical Pharmacology
|
December 10, 2019
The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)
Sine Donnellan, Daniel F B Wright, Jason A Roberts, et al.
Clinical Pharmacokinetics
|
December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study
Melanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
British Journal of Clinical Pharmacology
|
August 29, 2022
An allopurinol adherence tool using plasma oxypurinol concentrations
Natalia Smith-Diaz, Sophie L Stocker, Lisa K Stamp, et al.
British Journal of Clinical Pharmacology
|
March 6, 2014
Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran
Paul K L Chin, David M Patterson, Mei Zhang, et al.
British Journal of Clinical Pharmacology
|
March 14, 2018
'Massive' metformin overdose
Angela L Chiew, Daniel F B Wright, Nicola M Dobos, et al.
Clinical and Translational Science
|
August 25, 2019
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration
Lisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Therapeutic Drug Monitoring
|
November 18, 2016
Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool
Shamin M Saffian, Stephen B Duffull, Rebecca L Roberts, et al.
British Journal of Clinical Pharmacology
|
January 18, 2018
The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool
Daniel F B Wright, Nicola Dalbeth, Amanda J Phipps-Green, et al.
Nephrology (Carlton, Vic.)
|
April 16, 2024
The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout
Luke C Wilson, Jacob Ward, Daniel F B Wright, et al.
ACR Open Rheumatology
|
April 9, 2024
Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study
Toni J F Michael, Daniel F B Wright, Jian S Chan, et al.
European Journal of Clinical Pharmacology
|
December 10, 2019
The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)
Sine Donnellan, Daniel F B Wright, Jason A Roberts, et al.
Clinical Pharmacokinetics
|
December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study
Melanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
Page
of 8